Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial

NCT00565708 is registered in ClinicalTrials.gov with National Cancer Centre, Singapore as lead sponsor.

NCT NCT00565708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00565708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Lead sponsor
National Cancer Centre, Singapore
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2008
Completion date
June 30, 2024
Enrollment
1,587 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer